Diagnostic Traps in Papillary Thyroid Carcinoma: Correlation of The Bethesda System for Reporting Thyroid Cytopathology with Histopathology: A Case Series

Authors

  • Bindhuja Joseph Department of Pathology, Kanyakumari Medical Mission Research Centre and Hospitals, Muttom, India
  • Arya Prakash Department of Pathology, Kanyakumari Medical Mission Research Centre and Hospitals, Muttom, India
  • Kitty J Kuruvilla Department of Pathology, Kanyakumari Medical Mission Research Centre and Hospitals, Muttom, India

DOI:

https://doi.org/10.21276/apalm.3668

Keywords:

bethesda, cytology, thyroid, papillary carcinoma, follicular variant, niftp

Abstract

Fine-needle aspiration cytology is a widely used first-line tool for evaluating thyroid lesions, with histopathology serving as the diagnostic gold standard. Despite its advantages, interpretation challenges arise due to overlapping cytomorphologic features, suboptimal sample adequacy, and inter-observer variability, occasionally leading to discordance and affecting patient management. This case series describes four diagnostically challenging cases of classical papillary thyroid carcinoma in which initial cytological interpretations differed from final histopathological findings. Each case was re-evaluated systematically with emphasis on adequacy of the aspirate, radiologic correlation, characteristic cytological features, and potential diagnostic pitfalls. Contributing factors such as papillary hyperplasia mimics, misleading ultrasound impressions, and low cellularity were analyzed to understand the basis of discordance. Final diagnoses were established through multidisciplinary collaboration among the surgeon, radiologist, and cytopathologist. Case 1 was initially reported as a benign colloid nodule (TBSRTC II) but was later confirmed as classical papillary carcinoma with nodal metastasis. Case 2 was categorized as AUS (TBSRTC III); histopathology revealed classical papillary carcinoma, infiltrating follicular subtype. Case 3 was diagnosed as follicular neoplasm (TBSRTC IV) on cytology, while final evaluation confirmed NIFTP. Case 4, also categorized as follicular neoplasm (TBSRTC IV), was ultimately diagnosed as encapsulated angioinvasive follicular variant of papillary thyroid carcinoma. TBSRTC remains a robust and standardized framework for thyroid cytology, providing consistent terminology and risk stratification. However, diagnostic limitations persist, emphasizing the need for meticulous cytologic assessment, close radiologic correlation, and interdisciplinary collaboration to minimize discordance and improve patient outcomes.

References

1.Kamboj M, Mehta A, Pasricha S, Gupta G, Sharma A, Durga G. Cytomorphological categorization of thyroid lesions according to the Bethesda system for reporting thyroid cytology and correlation with their histological outcome: an Indian oncology centre experience. Journal of Cytology. 2022 Jan 1;39(1):44-50.

2.Kim JY, Kim EK, Lee HS, Kwak JY. Conventional papillary thyroid carcinoma: effects of cystic changes visible on ultrasonography on disease prognosis. Ultrasonography. 2014 Aug 11;33(4):291.

3.Fortuna GM, Rios P, Rivero A, Zuniga G, Dvir K, Pagacz MM, Manzano A. Papillary thyroid carcinoma with cystic changes in a patient with prior history of toxic nodule. Journal of Investigative Medicine High Impact Case Reports. 2020 Jul;8:2324709620942672

4.Harahap AS, Jung CK. Cytologic hallmarks and differential diagnosis of papillary thyroid carcinoma subtypes. Journal of Pathology and Translational Medicine. 2024 Nov 1;58(6):265-82..

5.Pusztaszeri M, Auger M. Update on the cytologic features of papillary thyroid carcinoma variants. Diagnostic cytopathology. 2017 Aug;45(8):714-30.

6.Yang GC, Fried KO, Scognamiglio T. Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: a review of 179 cases. Diagnostic cytopathology. 2017 Jun;45(6):533-41.

7.Macerola E, Proietti A, Basolo F. Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a new entity. Gland Surgery. 2020 Jan;9(Suppl 1):S47.

8.Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO classification of tumours of endocrine organs: WHO classification of tumours. International Agency for Research on Cancer: Lyon, French. 2017.

9.WHO classification of tumours of endocrine organs. 5th beta ed. [Internet]. Geneva: World Health Organization, 2022 [cited 2024 https://doi.org/10.4132/jptm.2024.09.14 49 Nguyen TP-X et al. May 20]. Available from: https://tumourclassification.iarc.who. int.

10. Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 2022; 33: 27- 63

11.Nguyen TP, Le MK, Roytrakul S, Shuangshoti S, Kitkumthorn N, Keelawat S. Diagnosis of invasive encapsulated follicular variant papillary thyroid carcinoma by protein-based machine learning. Journal of Pathology and Translational Medicine. 2024 Oct 24;59(1):39.

12.Ali SZ, VanderLaan PA, editors. The Bethesda system for reporting thyroid cytopathology: definitions, criteria, and explanatory notes. Springer Nature; 2023 Jun 29.

Downloads

Published

05-01-2026

Issue

Section

Case Report / Case Series

How to Cite

1.
Diagnostic Traps in Papillary Thyroid Carcinoma: Correlation of The Bethesda System for Reporting Thyroid Cytopathology with Histopathology: A Case Series. Ann of Pathol and Lab Med [Internet]. 2026 Jan. 5 [cited 2026 Jan. 7];13(1):C1-C7. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/3668